Perinatal granulopoiesis and risk of pediatric asthma

  1. Benjamin A Turturice  Is a corresponding author
  2. Juliana Theorell
  3. Mary Dawn Koenig
  4. Lisa Tussing-Humphreys
  5. Diane R Gold
  6. Augusto A Litonjua
  7. Emily Oken
  8. Sheryl L Rifas-Shiman
  9. David L Perkins  Is a corresponding author
  10. Patricia W Finn  Is a corresponding author
  1. University of Illinois at Chicago, United States
  2. Brigham and Women's Hospital, Harvard Medical School, United States
  3. University of Rochester, United States
  4. Harvard Medical School and Harvard Pilgrim Health Care Institute, United States

Abstract

There are perinatal characteristics, such as gestational age, reproducibly associated with risk for pediatric asthma. Identification of biologic processes influenced by these characteristics could facilitate risk stratification or new therapeutic targets. We hypothesized that transcriptional changes associated with multiple epidemiologic risk factors would be mediators of pediatric asthma risk. Using publicly available transcriptomic data from cord blood mononuclear cells, transcription of genes involved in myeloid differentiation were observed to be inversely associated with a pediatric asthma risk stratification based on multiple perinatal risk factors. This gene signature was validated in an independent prospective cohort and was specifically associated with genes localizing to neutrophil specific granules. Further validation demonstrated that umbilical cord blood serum concentration of PGLYRP-1, a specific granule protein, was inversely associated with mid-childhood current asthma and early-teen FEV1/FVCx100. Thus, neutrophil specific granule abundance at birth predicts risk for pediatric asthma and pulmonary function in adolescence.

Data availability

Data from RNAseq is available on NCBI Bioproject database PRJNA577955.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Benjamin A Turturice

    Department of Microbiology and Immunology, Department of Medicine, University of Illinois at Chicago, Chicago, United States
    For correspondence
    bturtu2@uic.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9382-4612
  2. Juliana Theorell

    Department of Medicine, University of Illinois at Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Mary Dawn Koenig

    Department of Women, Children and Family Health Science, University of Illinois at Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Lisa Tussing-Humphreys

    Department of Medicine and Cancer Center, University of Illinois at Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Diane R Gold

    Channing Division of Network Medicine, Department of Medicine, Department of Environmental Health, Harvard T.H. Chan School of Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Augusto A Litonjua

    Department of Pediatrics, University of Rochester, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Emily Oken

    Division of Chronic Disease Research Across the Life Course, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Sheryl L Rifas-Shiman

    Division of Chronic Disease Research Across the Life Course, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. David L Perkins

    Department of Medicine, University of Illinois at Chicago, Chicago, United States
    For correspondence
    perkinsd@uic.edu
    Competing interests
    The authors declare that no competing interests exist.
  10. Patricia W Finn

    Department of Microbiology and Immunology, Department of Medicine, Department of Bioengineering, University of Illinois at Chicago, Chicago, United States
    For correspondence
    pwfinn@uic.edu
    Competing interests
    The authors declare that no competing interests exist.

Funding

National Heart, Lung, and Blood Institute (F30HL136001)

  • Benjamin A Turturice

National Institute of Allergy and Infectious Diseases (R01AI053878)

  • Patricia W Finn

Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD034568)

  • Emily Oken

National Institutes of Health (UH3OD023286)

  • Emily Oken

Robert Wood Johnson Foundation (Nurse Faculty Scholars Program #72117)

  • Mary Dawn Koenig

University of Illinois at Chicago (College of Nursing Dean's Award)

  • Mary Dawn Koenig

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The current study was approved by the University of Illinois at Chicago IRB, 20160326 and 20150353, and the IRB of Harvard Pilgrim Health Care.

Copyright

© 2021, Turturice et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,487
    views
  • 130
    downloads
  • 2
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Benjamin A Turturice
  2. Juliana Theorell
  3. Mary Dawn Koenig
  4. Lisa Tussing-Humphreys
  5. Diane R Gold
  6. Augusto A Litonjua
  7. Emily Oken
  8. Sheryl L Rifas-Shiman
  9. David L Perkins
  10. Patricia W Finn
(2021)
Perinatal granulopoiesis and risk of pediatric asthma
eLife 10:e63745.
https://doi.org/10.7554/eLife.63745

Share this article

https://doi.org/10.7554/eLife.63745

Further reading

    1. Immunology and Inflammation
    Shih-Wen Huang, Yein-Gei Lai ... Nan-Shih Liao
    Research Article

    Natural killer (NK) cells can control metastasis through cytotoxicity and IFN-γ production independently of T cells in experimental metastasis mouse models. The inverse correlation between NK activity and metastasis incidence supports a critical role for NK cells in human metastatic surveillance. However, autologous NK cell therapy has shown limited benefit in treating patients with metastatic solid tumors. Using a spontaneous metastasis mouse model of MHC-I+ breast cancer, we found that transfer of IL-15/IL-12-conditioned syngeneic NK cells after primary tumor resection promoted long-term survival of mice with low metastatic burden and induced a tumor-specific protective T cell response that is essential for the therapeutic effect. Furthermore, NK cell transfer augments activation of conventional dendritic cells (cDCs), Foxp3-CD4+ T cells and stem cell-like CD8+ T cells in metastatic lungs, to which IFN-γ of the transferred NK cells contributes significantly. These results imply direct interactions between transferred NK cells and endogenous cDCs to enhance T cell activation. We conducted an investigator-initiated clinical trial of autologous NK cell therapy in six patients with advanced cancer and observed that the NK cell therapy was safe and showed signs of effectiveness. These findings indicate that autologous NK cell therapy is effective in treating established low burden metastases of MHC-I+ tumor cells by activating the cDC-T cell axis at metastatic sites.

    1. Cancer Biology
    2. Immunology and Inflammation
    Sofia V Krasik, Ekaterina A Bryushkova ... Ekaterina O Serebrovskaya
    Research Article

    The current understanding of humoral immune response in cancer patients suggests that tumors may be infiltrated with diffuse B cells of extra-tumoral origin or may develop organized lymphoid structures, where somatic hypermutation and antigen-driven selection occur locally. These processes are believed to be significantly influenced by the tumor microenvironment through secretory factors and biased cell-cell interactions. To explore the manifestation of this influence, we used deep unbiased immunoglobulin profiling and systematically characterized the relationships between B cells in circulation, draining lymph nodes (draining LNs), and tumors in 14 patients with three human cancers. We demonstrated that draining LNs are differentially involved in the interaction with the tumor site, and that significant heterogeneity exists even between different parts of a single lymph node (LN). Next, we confirmed and elaborated upon previous observations regarding intratumoral immunoglobulin heterogeneity. We identified B cell receptor (BCR) clonotypes that were expanded in tumors relative to draining LNs and blood and observed that these tumor-expanded clonotypes were less hypermutated than non-expanded (ubiquitous) clonotypes. Furthermore, we observed a shift in the properties of complementarity-determining region 3 of the BCR heavy chain (CDR-H3) towards less mature and less specific BCR repertoire in tumor-infiltrating B-cells compared to circulating B-cells, which may indicate less stringent control for antibody-producing B cell development in tumor microenvironment (TME). In addition, we found repertoire-level evidence that B-cells may be selected according to their CDR-H3 physicochemical properties before they activate somatic hypermutation (SHM). Altogether, our work outlines a broad picture of the differences in the tumor BCR repertoire relative to non-tumor tissues and points to the unexpected features of the SHM process.